The synergistic potential of camrelizumab and rivoceranib in advanced hepatocellular carcinoma: a review of current evidence.
Saved in:
| Title: | The synergistic potential of camrelizumab and rivoceranib in advanced hepatocellular carcinoma: a review of current evidence. |
|---|---|
| Authors: | Ahmed K; Department of Medicine, Dow Medical College, Karachi, Pakistan., Rehman A; Department of Medicine, Saidu Medical College, Swat, Pakistan., Devi B; Department of Medicine, Ziauddin Medical College, Karachi, Pakistan., Ul Haq S; Department of Medicine, Rahbar Medical and Dental College, Lahore, Pakistan., Malak A; Department of Medicine, Saidu Medical College, Swat, Pakistan., Zeb M; Department of Medicine, Saidu Medical College, Swat, Pakistan., Ariyasiri A; Department of Medicine, Dow International Medical College, Karachi, Pakistan., Memon R; Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan., Kashif Z; Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan., Shamsher Z; Department of Medicine, Saidu Medical College, Swat, Pakistan., Ullah B; Department of Medicine, Saidu Medical College, Swat, Pakistan., Kanwal W; Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan., Hasanain M; Department of Medicine, Dow Medical College, Karachi, Pakistan., Mahmmoud Fadelallah Eljack M; Department of Medicine, Community Department, University of Bakht Alruda, Ad Duwaym, Sudan. |
| Source: | Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2025 Jul 18; Vol. 87 (9), pp. 5598-5606. Date of Electronic Publication: 2025 Jul 18 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wolters Kluwer Country of Publication: England NLM ID: 101616869 Publication Model: eCollection Cited Medium: Print ISSN: 2049-0801 (Print) Linking ISSN: 20490801 NLM ISO Abbreviation: Ann Med Surg (Lond) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
